Cerebral aspergillosis: long term efficacy and safety of liposomal amphotericin B in kidney transplant

被引:10
|
作者
Carlini, A [1 ]
Angelini, D
Burrows, L
De Quirico, G
Antonelli, A
机构
[1] Campo Marte Hosp, Dept Nephrol, I-55100 Lucca, Italy
[2] Campo Marte Hosp, Dept Radiol, I-55100 Lucca, Italy
[3] Mt Sinai Hosp, Dept Renal Transplantat, New York, NY 10029 USA
关键词
cerebral aspergillosis; liposomal amphotericin B; nefrotoxicity; renal transplant;
D O I
10.1093/ndt/13.10.2659
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
[No abstract available]
引用
收藏
页码:2659 / 2661
页数:3
相关论文
共 50 条
  • [1] Cerebral aspergillosis in a liver transplant recipient: a case report of long-term survival after combined treatment with liposomal amphotericin B and surgery
    Iemmolo, RM
    Rossanese, A
    Rotilio, A
    Mattisi, G
    Gerunda, GE
    Merenda, R
    Neri, D
    Crepaldi, G
    Strazzabosco, M
    JOURNAL OF HEPATOLOGY, 1998, 28 (03) : 518 - 522
  • [2] Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients
    Andstrom, EE
    Ringden, O
    Remberger, M
    Svahn, BM
    Tollemar, J
    MYCOSES, 1996, 39 (5-6) : 185 - 193
  • [3] Efficacy of high doses of liposomal amphotericin B in the treatment of experimental aspergillosis
    Martín, MT
    Gavaldà, J
    López, P
    Gomis, X
    Ramírez, JL
    Rodríguez, D
    Len, O
    Jordano, Q
    Ruiz, I
    Rosal, M
    Almirante, B
    Pahissa, A
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (06) : 1032 - 1034
  • [4] Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis
    Gavaldà, J
    Martín, MT
    López, P
    Gomis, X
    Ramírez, JL
    Rodríguez, D
    Len, O
    Puigfel, Y
    Ruíz, I
    Pahissa, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) : 3028 - 3030
  • [5] LIPOSOMAL AMPHOTERICIN-B TREATMENT OF ASPERGILLOSIS IN A RENAL-TRANSPLANT PATIENT
    ELLIS, ME
    BOHLEGA, S
    HALIM, MA
    QUNIBI, W
    THARPE, W
    SAUDI MEDICAL JOURNAL, 1993, 14 (05) : 469 - 470
  • [6] Liposomal amphotericin B (AmBisome®) in invasive aspergillosis
    Calviño, J
    Lens, XM
    Romero, R
    Galbán, C
    Novoa, D
    Mardaras, J
    Arcocha, V
    Sánchez-Guisande, D
    NEFROLOGIA, 1999, 19 (04): : 294 - 298
  • [7] Safety and tolerance of liposomal amphotericin B in the treatment of invasive aspergillosis in a neutropenic adolescent
    Gandemer, V
    Taque, S
    Guiguen, C
    Rambeau, M
    Sayagh, M
    Le Gall, E
    JOURNAL DE MYCOLOGIE MEDICALE, 2000, 10 (02): : 105 - 107
  • [8] Efficacy and safety of generic amphotericin B in experimental pulmonary aspergillosis
    Petraitis, V
    Petraitiene, R
    Lin, PX
    Calis, K
    Kelaher, AM
    Muray, HA
    Mya-San, C
    Mickiene, D
    Bacher, J
    Walsh, TJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (04) : 1642 - 1645
  • [9] Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B
    Groll, Andreas H.
    Rijnders, Bart J. A.
    Walsh, Thomas J.
    Adler-Moore, Jill
    Lewis, Russell E.
    Bruggemann, Roger J. M.
    CLINICAL INFECTIOUS DISEASES, 2019, 68 : S260 - S274
  • [10] LIPOSOMAL AMPHOTERICIN-B FOR TREATMENT OF PULMONARY ASPERGILLOSIS IN A HEART-TRANSPLANT PATIENT
    KATZ, NM
    PIERCE, PF
    ANZECK, RA
    VISNER, MS
    CANTER, HG
    FOEGH, ML
    PEARLE, DL
    TRACY, C
    RAHMAN, A
    JOURNAL OF HEART TRANSPLANTATION, 1990, 9 (01): : 14 - 17